RE:RE:RE:Resistance at 0.31cents Just look at the cannabis penny stocks compared to the other ones, the typical nickel to penny fluctuation day in, day out. Until we get traction this will be non stop.
It is my opinion Supreme is presently working on correcting this in order to bring value to shareholders. Doesn't take a brain surgeon to figure out Supreme only requires market share to have at a minimum a 300 million company. The facility is completed, they have proven they can deliver, no one is near their capability at producing quality product at scale.
They will surpass numerous companies in 2021 which are above the $1.00 mark. Just dissect Organigram, Sundial, Cronos etc, and It is insane Supreme is sitting at .30. They're ahead on so many different fronts.
Seems like investors are hypnotized by the major companies, but do you prefer being part of a company with 800 million in losses or Supreme's balance sheet.
I never read analysts report when dealing with blue chip companies, I strictly base my decisions on fundamentals and balance sheets. But with a penny stock the herd mentality takes over and it is almost a necessity in order to get pass the mud hole.
This company has the goods, and should have a valuation based on the industry. Base on numbers do you think Organigram is a $4.00 a share company, or Cronos an above $10.00 a share company.
The outstanding shares story is getting old, in the last 15 years I've witnessed good companies manoeuvre around the same issue and be successful without RS etc. Beena is smart and I'm confident she'll continue growing this company the right way. IMHO
with how this industry is valuated there is no reason why this company couldn't sustain a $1.00 SP. IMHO